摘要
目的探讨静脉输液治疗时输液管中不同液体的配伍变化,为临床安全用药提供参考。方法收集滴注药液做配伍实验,查阅药品说明书和相关文献进行分析。结果五组滴注药物存在配伍禁忌(奥硝唑与头孢地秦钠,奥硝唑与头孢唑肟钠,头孢哌酮与10%葡萄糖液,氟罗沙星与穿琥宁,丹参液与氯化钾)。结论药物的配伍变化常发生在联合给药,尤其是联合输液时,采用有效措施与方法可以避免药物的配伍反应。对尚未列入注射液配伍禁忌表中的新药,使用时更应注意加强观察,及时发现异常情况,妥善处理,防止反应物进入人体产生不良影响。
Objective To investigate the intravenous infusion treatment in different liquid of tubing feng-chi,to provide reference for safe use of medicine in clinic.Methods We collected drip liquor for compatibility experiment,looked up drug manuals and relevant literature and analyzed.Results Five groups of drip drugs had taboo compatibility（ornidazole and sodium chin cephalosporins,ornidazole and cefazolin sodium,cefoperazone and 10% glucose,fleroxacin and chuanhuning,salvia miltiorrhiza fluid and potassium chloride）.Conclusions Drug compatibility changes often happen in combined chemotherapy,especially when combined infusion.Effective methods can avoid drug compatibility reaction.For new drugs not listed in the injection drug compatibility taboo tables,we should observe,timely find out abnormal situations and properly handle when using to prevent the reactants from entering human body with harmful effects.
出处
《临床医学工程》
2011年第1期120-121,共2页
Clinical Medicine & Engineering
关键词
输液
药物配伍
配伍反应
Transfusion
Drug compatibility
Compatibility reaction
